219 related articles for article (PubMed ID: 37460984)
21. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
22. Comparison of cardio-focal and chest reconstruction of technetium-99m pyrophosphate scintigraphy for diagnosis of transthyretin cardiac amyloidosis: a quality assurance study.
Akincioglu C; Murthi M; Romsa J; Warrington J; Malhotra S
J Nucl Cardiol; 2023 Dec; 30(6):2607-2614. PubMed ID: 37012525
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
[TBL] [Abstract][Full Text] [Related]
24. Inter-observer reproducibility and intra-observer repeatability in
Singh V; Cuddy S; Kijewski MF; Park MA; Taylor A; Taqueti VR; Skali H; Blankstein R; Falk RH; Di Carli MF; Dorbala S
J Nucl Cardiol; 2022 Apr; 29(2):440-446. PubMed ID: 32918247
[TBL] [Abstract][Full Text] [Related]
25. Utility of
Tsutsui Y; Kubota T; Kato S; Nozoe M; Suematsu N; Okabe M; Yamamoto Y; Tsutsui H
Circ Rep; 2019 Jun; 1(7):277-285. PubMed ID: 33693151
[No Abstract] [Full Text] [Related]
26. Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population.
Bourque JM; Schepart A; Bhambri R; Castaño A; O'Brien A; Chen Y; Prasad S; Roy A; Grodin JL
Am J Cardiol; 2022 Mar; 167():98-103. PubMed ID: 35022130
[TBL] [Abstract][Full Text] [Related]
27. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
28. Molecular imaging of amyloidosis: will the heart be the next target after the brain?
Chen W; Dilsizian V
Curr Cardiol Rep; 2012 Apr; 14(2):226-33. PubMed ID: 22193845
[TBL] [Abstract][Full Text] [Related]
29. [Myocardial scintigraphic studies with 123I-MIBG, 201Tl and 99mTc-PYP in patients with cardiac amyloidosis].
Fujii T; Tanaka M; Yazaki Y; Kitabayashi H; Koizumi T; Hongo M; Sekiguchi M; Itoh A; Gomi T; Yano K
Kaku Igaku; 1997 Nov; 34(11):1033-9. PubMed ID: 9455044
[TBL] [Abstract][Full Text] [Related]
30. Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.
Papantoniou V; Valsamaki P; Kastritis S; Tsiouris S; Delichas Z; Papantoniou Y; Tsiouma M; Athanasoulis T; Fotopoulos A; Dimopoulos MA
Hell J Nucl Med; 2015; 18 Suppl 1():42-50. PubMed ID: 26665211
[TBL] [Abstract][Full Text] [Related]
31. Amyloid deposit corresponds to technetium-99m-pyrophosphate accumulation in abdominal fat of patients with transthyretin cardiac amyloidosis.
Takahashi K; Sasaki D; Yamashita M; Sakaue T; Enomoto D; Morioka H; Uemura S; Okura T; Ikeda S; Kono T; Hiratsuka Y; Saijo A; Yamamura N; Kitazawa S; Yamashita T; Ueda M
J Nucl Cardiol; 2022 Dec; 29(6):3126-3136. PubMed ID: 34964085
[TBL] [Abstract][Full Text] [Related]
32. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
33. Amyloidosis of heart and liver: comparison of Tc-99m pyrophosphate and Tc-99m methylene diphosphonate for detection.
Lee VW; Caldarone AG; Falk RH; Rubinow A; Cohen AS
Radiology; 1983 Jul; 148(1):239-42. PubMed ID: 6304810
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc
Pandey S; Teruya S; Rodriguez C; Deluca A; Kinkhabwala M; Johnson LL; Fine D; Sabogal N; Winburn M; Castillo M; Bhatia K; Malkovskaya R; Raiszadeh F; Kurian D; Miller EJ; Einstein AJ; Maurer MS; Ruberg FL
J Nucl Cardiol; 2023 Aug; 30(4):1414-1419. PubMed ID: 36823486
[TBL] [Abstract][Full Text] [Related]
35. Follow-up Tc-99 m pyrophosphate cardiac scan for patients with transthyretin cardiac amyloidosis treated with tafamidis.
Lee TH; Wang YF; Hu LH; Peng NJ; Chang CY; Huang WS
Jpn J Radiol; 2023 Aug; 41(8):882-888. PubMed ID: 36920732
[TBL] [Abstract][Full Text] [Related]
36. Usefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathy.
Rapezzi C; Quarta CC; Guidalotti PL; Longhi S; Pettinato C; Leone O; Ferlini A; Salvi F; Gallo P; Gagliardi C; Branzi A
Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):470-8. PubMed ID: 21069320
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
Cappelli F; Gallini C; Di Mario C; Costanzo EN; Vaggelli L; Tutino F; Ciaccio A; Bartolini S; Angelotti P; Frusconi S; Farsetti S; Vergaro G; Giorgetti A; Marzullo P; Genovesi D; Emdin M; Perfetto F
J Nucl Cardiol; 2019 Apr; 26(2):497-504. PubMed ID: 28537040
[TBL] [Abstract][Full Text] [Related]
38. Association Between Atrial Uptake on Cardiac Scintigraphy With Technetium-99m-Pyrophosphate Labeled Bone-Seeking Tracers and Atrial Fibrillation.
Hussain M; Krywanczyk A; Donnellan E; Martyn T; Hassan OA; Alkharabsheh S; Watson C; Tang WH; Kwon D; Cremer P; Cheng F; Kanj M; Griffin B; Tan C; Rodriguez ER; Hanna M; Jaber W; Collier P
Circ Cardiovasc Imaging; 2022 May; 15(5):e013829. PubMed ID: 35580157
[TBL] [Abstract][Full Text] [Related]
39. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
40. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
